At Zentiva, we provide health and wellbeing for all generations

We develop, produce, and deliver high-quality, affordable medicines to more than 100 million people in over 30 countries across Europe and beyond. Our team of 5,000 unique talents share a commitment to the people who depend on our medicines every day.

Sustainability in Action

Dr RK Nair shares his vision for Reforestation in latest Zentiva Podcast

Zentiva joins UN Target Gender Equality Accelerator

Gender equality is not only a fundamental human right – it is also a powerful driver of business success. As a pan-European company, we have both the responsibility and the opportunity to lead in advancing gender equality across the continent and beyond.

Zentiva Climate Targets Officially Validated by the Science-Based Targets Initiative (SBTi)

Zentiva is proud to announce a significant step forward in its sustainability strategy with official validation of its targets by the Science Based Targets initiative (SBTi). 

Zentiva and Lupin Sign License and Supply Agreement for Biosimilar

Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for commercialization of Lupin!s biosimilar, TNF alpha inhibitor medicine, across multiple markets globally.

Zentiva calls for Pause - Repair - Relaunch of the Urban Wastewater Treatment Directive (UWWTD)

As the EU adapts to global geopolitical tensions and renews its focus on simplifying legislation, Medicines for Europe convened policymakers, industry leaders, and partners for its annual meeting in Brussels.